EP 3116996 A2 20170118 - TREATMENT OF RESISTANT LESIONS
Title (en)
TREATMENT OF RESISTANT LESIONS
Title (de)
BEHANDLUNG VON RESISTENTEN LÄSIONEN
Title (fr)
TRAITEMENT DE LÉSIONS RÉSISTANTES
Publication
Application
Priority
- US 201461953604 P 20140314
- US 201461953608 P 20140314
- US 2015020786 W 20150316
Abstract (en)
[origin: WO2015139047A2] Connexin protein modulation methods and compositions are provided for the healing of resistant lesions, including lesions on subjects with multiple venous leg ulcers or multiple diabetic foot ulcers, and other responder subjects. Also provided are kits and articles of manufacture comprising a connexin protein modulating agent, for example, a connexin 43 modulating agent for use in the healing of resistant lesions.
IPC 8 full level
C12N 15/11 (2006.01); A61K 38/00 (2006.01); C07H 21/04 (2006.01)
CPC (source: EP)
A61K 31/7088 (2013.01); C12N 15/1138 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015139047 A2 20150917; WO 2015139047 A3 20151210; CA 2941140 A1 20150917; EP 3116996 A2 20170118; EP 3116996 A4 20180110
DOCDB simple family (application)
US 2015020786 W 20150316; CA 2941140 A 20150316; EP 15760904 A 20150316